Interventional Oncology Market 2022 Share, Trend, Segmentation and Forecast To 2026

Posted by Jignesh J on November 11th, 2022

The Global Interventional Oncology Market was valued at USD 1.9 billion in 2020 and is expected to register a CAGR of 6.8% during the forecast period (2021 – 2026). The report studies the market scenario and its growth prospects during the forecast period. In addition, the report includes a detailed analysis of the leading competitors functioning in this market.

The market research report on the Interventional Oncology industry analyzes the overall estimates of all the segments and sub-segments of the market, on a global and regional scale. The report presents the historical data for the time period 2017-2021, revenue estimates from 2021-2026, and forecasts from 2021 till 2026. The report presents a detailed analysis of the market trends, market dynamics, leading competitors, technological innovations and inventions, key developments, lucrative opportunities, and future strategies. The market size is calculated on the basis of the financials generated through sales from the mentioned segments and sub-segments in this research study. The overall market has been analyzed using the top-down and bottom-up approaches for data validation and accuracy measures.

Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164

Prominent Players:

Medtronic (Ireland), Boston Scientific (US), BD (US), Terumo (Japan), Merit Medical (US), AngioDynamics (US), J&J (US), Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves (US), Sanarus (US), IMBiotechnologies (Canada), Trod Medical (US), IceCure Medical (Israel), Mermaid Medicals (Denmark), Interface Biomaterials BV (Netherlands), Guerbet (France), ABK Biomedical (Canada), Shape Memory Medical (US), Endo Shape (US), Monteris Medical (US), Instylla (US), Trisalus Lifesciences (US), Profound Medical Corp (Canada), Sirtex (US), Accuray (US), Baylis Medical (Canada), ALPINION MEDICAL SYSTEMS (South Korea) and Among others.

The Global Interventional Oncology Market is defined by the presence of some of the leading competitors operating in the market, including the well-established players and new entrants, and the suppliers, vendors, and distributors. The key players are continuously focusing on expanding their geographic reach and broadening their customer base, in order to expand their product portfolio and come up with new advancements. The report also analyzes the development proposals and the feasibility of new investments. This report has been collated in order to provide guidance and direction to the companies and individuals interested in buying this research report.

This research report categorizes the interventional oncology market based on product, procedure, cancer type, end user, and region.

By Product

• Embolization Devices

o    Radioembolic Agents

o    Non-Radio embolic Agents

• Microspheres
• Coated Beads
• Microparticles

• Ablation Devices

o    Radiofrequency (RF) Ablation Devices

o    Microwave Ablation Devices

o    Cryoablation Devices

o    Other Ablation Devices

• Support Devices

o    Microcatheters

o    Guidewires

By Procedure

• Thermal Tumor Ablation
• Non-Thermal Tumor Ablation
• Transcatheter Arterial Chemoembolization
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
• Transcatheter Arterial Embolization/Bland Embolization

By Cancer Type

• Liver Cancer
• Lung Cancer
• Bone Metastasis
• Kidney Cancer
• Breast Cancer
• Prostate Cancer
• Other Cancers

By End Users

• Hospitals
• Ambulatory Surgery Centers
• Research & Academic Institutes

Request a Sample Copy of Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=203687164

Some of the key geographies mentioned in this report include:

• North America (U.S and Canada and rest of North America)
• Europe (Germany, France, Italy and Rest of Europe)
• Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific)
• LAMEA (Brazil, Turkey, Saudi Arabia, South Africa and Rest of LAMEA)